was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis...

Rhône-Poulenc S.A. in 1999. With the new company's 2004 merger with Sanofi-Synthélabo, it became a subsidiary of the resulting Sanofi-Aventis pharmaceuticals...

on 10 May 2017. Retrieved 24 August 2016. Conard D (17 October 1991). "Synthélabo rachète les laboratoires Delagrange". Lesechos.fr. Les Echos. Archived...

purchased Synthélabo in 1973 to pursue its ambitions in the pharmaceutical field. Synthélabo merged with Sanofi in 1999 to become Sanofi-Synthélabo. Sanofi-Synthélabo...

Hoechst AG to form Aventis. In 2004, Aventis went on to merge with Sanofi-Synthélabo forming Sanofi-Aventis, the third-largest pharmaceutical company in the...

01425.x. PMID 19906028. S2CID 35544028. Conard D (17 October 1991). "Synthélabo rachète les laboratoires Delagrange". Les Echos. "Laboratoires Delagrange"...

Rhône-Poulenc to become Aventis in 1999 and in 2004 Aventis merged with Sanofi-Synthélabo to become Sanofi-Aventis. In 2005, around 22,000 people worked at Industriepark...

1999, two French pharmaceutical companies, Sanofi and Synthélabo, merged to form Sanofi-Synthélabo. Soon after the merger, the new company divested several...

used in Europe starting in 1988 and was brought to market there by Synthelabo. Synthelabo and Searle collaborated to bring it to market in the US, and it...

fully automated trading system. CAC 5 consisted of Leroy-Somer, LVMH, Synthélabo, Eurocom and UCB. CAC 40's base value of 1,000 was set on 31 December...

Delagrange/Sanofi-Synthélabo Thioridazine Tricyclic/Phenothiazine Typical Melleril 1958 Novartis Tiapride Benzamide Disputed Tiapridal 1975 Sanofi-Synthélabo Tiotixene...

molecular weight heparins (LMWHs). Nadroparin was developed by Sanofi-Synthélabo. Nadroparin is used in general and orthopedic surgery to prevent thromboembolic...

Apotex Inc v Sanofi-Synthelabo Canada Inc, [2008] 3 S.C.R. 265, is a leading Supreme Court of Canada decision on the novelty and non-obviousness requirements...

Rhône-Poulenc to form Aventis, which then merged in 2004 with Sanofi-Synthélabo to form Sanofi-Aventis, which was since renamed Sanofi. Hoechst Schering...

v t e Sanofi Predecessors Sanofi-Synthélabo Aventis Hoechst Rhône-Poulenc Cassella Roussel Uclaf Marion Merrell Dow CEOs Chris Viehbacher Olivier Brandicourt...

International Inc. v. Tabur Marine (Great Britain) Ltd. in Apotex Inc. v. Sanofi‑Synthelabo Canada Inc.: Identify the notional "person skilled in the art" and identify...

Sanofi-Aventis – Sanofi-Aventis Ltd Sanofi Pasteur – Sanofi Pasteur MSD Ltd Sanofi-Synthélabo – Sanofi-Aventis Ltd Schering-Plough – Schering-Plough Ltd Schwarz – Schwarz...

brand names, including Deltalin (Eli Lilly and Company), Drisdol (Sanofi-Synthelabo), and Calcidol (Patrin Pharma).[citation needed] "Summary Basis of Decision...

merging with Rhône-Poulenc to form Aventis, which later merged with Sanofi-Synthélabo to form Sanofi. Two years earlier, another part of Hoechst was sold in...

for Oral Use. Prescribing Information". rlsnet.ru (in Russian). Sanofi-Synthelabo. Archived from the original on 16 August 2016. Retrieved 14 July 2016...

Tolgabide (INN; development code SL-81.0142) is a drug which was patented by Synthélabo as an anticonvulsant but was never marketed. It is an analogue of progabide...

19–25. doi:10.1021/jm00151a003. Philippe M. Manoury, US4315007 (1982 to Synthelabo SA); CA, 96, 162737e. Keshav Deo, et al. WO2009001369 (to Alembic Ltd...

(Sanofi S.R.L. Italy) Depakine (Sanofi Aventis France) Depakine (Sanofi Synthelabo Romania) Depalept (Sanofi Aventis Israel) Deprakine (Sanofi Aventis Finland)...

v t e Sanofi Predecessors Sanofi-Synthélabo Aventis Hoechst Rhône-Poulenc Cassella Roussel Uclaf Marion Merrell Dow CEOs Chris Viehbacher Olivier Brandicourt...

Apo-Primidone, Liskantin (Germany, Desitin), Resimatil (Germany, Sanofi-Synthélabo GmbH), Mylepsinum (Germany, AWD.pharma GmbH & Co., KG)., and Sertan (Hungary...

Standard. 7 April 1997. Retrieved 28 May 2024. "Torrent exits JV with Sanofi-Synthelabo: Reuters". Rediff. Retrieved 28 May 2024. "Torrent to buy Pfizer group's...

Pharmaceuticals Acquires Mebaral(R), Chemet(R), and Winstrol(R) From Sanofi-Synthelabo Inc". PRnewswire. 7 August 2003. "Press Release: GTCR Completes the Sale...

trial for the treatment of acute ischemic stroke in 1996, sponsored by Synthélabo Recherche. NMDA receptors are a key component in mediating glutamate-induced...

Gabriel Tarde, La Logique sociale (préface), Le Plessis-Robinson, Institut Synthélabo pour le progrès de la connaissance, 1999, coll. « Les Empêcheurs de penser...

United States or the United Kingdom. It is marketed in Brazil by Sanofi-Synthélabo under the trade name Digesan, by LIBBS under the name Plamet, and as a...